Postoperative Dysphagia After Magnetic Sphincter Augmentation: Risk Factors and Management

Overview

Magnetic sphincter augmentation (MSA) is an effective surgical treatment for GERD with a favorable side effect profile compared to laparoscopic Nissen fundoplication. However, postoperative dysphagia remains the most common complication, occurring in 43–83% of patients early after surgery, with some cases persisting and requiring intervention. This study characterizes dysphagia after MSA, identifies preoperative predictors, and reviews management strategies.

Background

Gastroesophageal reflux disease (GERD) affects approximately 25% of adults in the USA and is commonly treated with proton-pump inhibitors or laparoscopic fundoplication. Limitations of medical therapy and concerns about fundoplication side effects have led to the adoption of magnetic sphincter augmentation (MSA) since FDA approval in 2012. MSA offers comparable reflux control with fewer side effects such as gas bloating and impaired belching. Despite this, postoperative dysphagia is frequently reported and can persist, necessitating further clinical attention.

Data Highlights

Early postoperative dysphagia incidence ranges from 43% to 83%. Approximately 30,000 LINX devices have been implanted worldwide since 2012. GERD affects 25% of adults in the USA, with nearly 40% experiencing breakthrough symptoms on PPI therapy. DeMeester score >14.7 defines abnormal acid exposure.

Key Findings

• Postoperative dysphagia is the most common complaint after MSA, occurring in 43–83% of patients early postoperatively.
• Most dysphagia resolves within 8 weeks, but persistent symptoms may require endoscopic dilation or device removal.
• Preoperative evaluation includes GERD-HRQL questionnaire, esophagogastroduodenoscopy, high-resolution impedance manometry, and pH or impedance-pH monitoring.
• Patients with prior esophageal or gastric surgery, significant dysmotility, or titanium allergy were excluded from MSA candidacy.
• Hiatal hernia presence is not a contraindication to MSA.
• MSA provides comparable reflux control to laparoscopic Nissen fundoplication with fewer side effects like gas bloating and preserved ability to belch or vomit.

Clinical Implications

Clinicians should anticipate early postoperative dysphagia in patients undergoing MSA and counsel accordingly. Preoperative assessment including manometry and pH testing is essential to identify suitable candidates and predict risk. Persistent dysphagia warrants timely evaluation and may require endoscopic dilation or device removal to optimize outcomes.

Conclusion

Magnetic sphincter augmentation is a safe and effective surgical option for GERD with a favorable side effect profile, though postoperative dysphagia remains a significant concern. Careful patient selection and management strategies are critical to minimize and address this complication.

References

1. Allegheny Health Network Study 2013-2018 -- Postoperative Dysphagia Following Magnetic Sphincter Augmentation